Maithri Drugs: Dedicated to your API needs.
01 1Maithri Drugs Private Limited
01 1LITHIUM CITRATE
01 1India
Maithri Drugs: Dedicated to your API needs.
NDC Package Code : 70600-084
Start Marketing Date : 2026-02-18
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
99
PharmaCompass offers a list of Lithium Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Lithium Citrate manufacturer or Lithium Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lithium Citrate manufacturer or Lithium Citrate supplier.
A lithium citrate (anh.) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of lithium citrate (anh.), including repackagers and relabelers. The FDA regulates lithium citrate (anh.) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. lithium citrate (anh.) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of lithium citrate (anh.) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A lithium citrate (anh.) supplier is an individual or a company that provides lithium citrate (anh.) active pharmaceutical ingredient (API) or lithium citrate (anh.) finished formulations upon request. The lithium citrate (anh.) suppliers may include lithium citrate (anh.) API manufacturers, exporters, distributors and traders.
click here to find a list of lithium citrate (anh.) suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing lithium citrate (anh.) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for lithium citrate (anh.) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture lithium citrate (anh.) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain lithium citrate (anh.) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a lithium citrate (anh.) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of lithium citrate (anh.) suppliers with NDC on PharmaCompass.
We have 1 companies offering lithium citrate (anh.)
Get in contact with the supplier of your choice:
